 | Silmitasertib | IC50 | 14.7 [1] |
 | 4,5,6,7-Tetrabromobenzotriazole | IC50 | 320.0 [1], 500.0 [2], 900.0 [3], 1480.0 [4] |
| 4,5,6,7-Tetrabromobenzotriazole | Ki | 400.0 [1] |
 | 4,5,6,7-Tetrabromobenzimidazole | IC50 | 170.0 [1], 1300.0 [2] |
| 4,5,6,7-Tetrabromobenzimidazole | Ki | 45.0 [1], 315.0 [2], 462.0 [3], 1030.0 [4] |
 | Emodin | IC50 | 890.0 [1], 2000.0 [2] |
| Emodin | Ki | 1850.0 [1], 40000.0 [2] |
 | 4,5,6,7-Tetrabromo-N,N-dimethyl-1H-benzimidazol-2-amine | Ki | 40.0 [1], 97.0 [2], 139.0 [3] |
 | (5-Oxo-5,6-dihydro-indolo[1,2-A]quinazolin-7-YL)-acetic acid | IC50 | 390.0 [1] |
| (5-Oxo-5,6-dihydro-indolo[1,2-A]quinazolin-7-YL)-acetic acid | Ki | 170.0 [1] |
 | 4-[2-[(4-Methoxyphenyl)carbonylamino]-1,3-Thiazol-5-Yl]benzoic Acid | IC50 | 20.0 [1], 32.0 [2] |
 | CID 72163809 | IC50 | 3.0 [1] |
 | N-[1-[3-Cyano-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-5-yl]indol-6-yl]acetamide | IC50 | 10.0 [1] |
 | N-[1-[3-Cyano-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-5-yl]indol-6-yl]-N-methylacetamide | IC50 | 10.0 [1], 11.0 [2], 34.0 [3] |
 | 3-[5-Acetamido-3-[3-cyano-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-5-yl]indol-1-yl]propanoic acid | IC50 | 3.0 [1], 3000.0 [2], 3100.0 [3] |
 | Apigenin | IC50 | 800.0 [1] |
| Apigenin | Ki | 740.0 [1] |
 | 5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole | IC50 | 13000.0 [1] |
| 5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole | Ki | 4500.0 [1] |
 | 4-(7-Butyl-5H-pyrrolo[2,3-b]pyrazin-6-yl)phenol | IC50 | 100000.0 [1] |
 | 4,5,6,7-Tetraiodo-1H-benzimidazole | Ki | 43.0 [1], 266.0 [2] |
 | 5-((3-Ethynylphenyl)amino)pyrimido[4,5-c]quinoline-8-carboxylic acid | IC50 | 6.0 [1], 98.0 [2] |
 | [4,5,6,7-Tetrabromo-2-(Dimethylamino)-1h-Benzimidazol-1-Yl]acetic Acid | Ki | 83.0 [1], 88.0 [2] |
 | 3-(Cyclopropylamino)-5-{[3-(Trifluoromethyl)phenyl]amino}pyrimido[4,5-C]quinoline-8-Carboxylic Acid | IC50 | 10.0 [1], 750.0 [2] |
 | ((4,5,6,7-Tetrabromo-1H-benzimidazol-2-yl)sulfanyl)-acetic acid | Ki | 106.0 [1], 170.0 [2] |
 | 4,5,6,7-Tetrabromo-N,N,1-trimethylbenzimidazol-2-amine | Ki | 154.0 [1], 212.0 [2] |
 | N-[3-[3-Cyano-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-5-yl]-1H-indol-5-yl]acetamide | IC50 | 77.0 [1], 5000.0 [2] |
 | 2-[(4,5,6,7-Tetraiodo-1H-benzimidazol-2-yl)sulfanyl]acetic acid | Ki | 80.0 [1], 110.0 [2] |
 | 2-(4,5,6,7-Tetraiodobenzimidazol-1-yl)acetic acid | Ki | 261.0 [1], 378.0 [2] |
 | (4,5,6,7-Tetrabromo-1h-Benzimidazol-1-Yl)acetic Acid | Ki | 670.0 [1], 798.0 [2] |
 | 5-(2-Amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-tert-butylpyridine-3-sulfonamide | IC50 | 10000.0 [1] |
 | 4-[(4,5,6,7-Tetrabromo-1H-benzimidazol-2-yl)sulfanyl]butanoic acid | Ki | 77.0 [1], 210.0 [2] |
 | 4-[6-[6-(Propan-2-ylamino)indazol-1-yl]pyrazin-2-yl]benzoic acid | IC50 | 5.0 [1], 110.0 [2] |
 | 3-Chloro-4-[6-[6-(propan-2-ylamino)indazol-1-yl]pyrazin-2-yl]benzoic acid | IC50 | 15.0 [1], 3400.0 [2] |
 | 3-Fluoro-4-[6-[6-(propan-2-ylamino)indazol-1-yl]pyrazin-2-yl]benzoic acid | IC50 | 5.0 [1], 340.0 [2] |
 | 6-[6-[6-(Propan-2-ylamino)indazol-1-yl]pyrazin-2-yl]pyridine-3-carboxylic acid | IC50 | 7.0 [1], 1000.0 [2] |
 | 4-[6-[6-(Propan-2-ylamino)indazol-1-yl]pyrazin-2-yl]thiophene-2-carboxylic acid | IC50 | 26.0 [1], 3300.0 [2] |
 | 4-[6-[6-(Propan-2-ylamino)indol-1-yl]pyrazin-2-yl]benzoic acid | IC50 | 3.0 [1], 96.0 [2] |
 | 2-Fluoro-4-[6-[6-(propan-2-ylamino)indazol-1-yl]pyrazin-2-yl]benzoic acid | IC50 | 7.0 [1], 180.0 [2] |
 | 5-[6-[6-(Propan-2-ylamino)indazol-1-yl]pyrazin-2-yl]pyridine-2-carboxylic acid | IC50 | 297.0 [1], 4300.0 [2] |
 | 5-Anilinobenzo[c][2,6]naphthyridine-8-carboxylic acid | IC50 | 10.0 [1], 7400.0 [2] |
 | 5-[2-(Dimethylamino)ethylamino]benzo[c][2,6]naphthyridine-8-carboxylic acid | IC50 | 19.0 [1], 50000.0 [2] |
 | 5-(2-Phenylethylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid | IC50 | 3.0 [1], 688.0 [2] |
 | 5-(3-Phenylpropylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid | IC50 | 16.0 [1], 2500.0 [2] |
 | 5-(3-Methoxyanilino)benzo[c][2,6]naphthyridine-8-carboxylic acid | IC50 | 7.0 [1], 2325.0 [2] |
 | 5-(3-Chloro-4-fluoroanilino)benzo[c][2,6]naphthyridine-8-carboxylic acid | IC50 | 6.0 [1], 464.0 [2] |
 | 5-(3-Fluoroanilino)benzo[c][2,6]naphthyridine-8-carboxylic acid | IC50 | 5.0 [1], 2933.0 [2] |
 | 5-(4-Chloroanilino)benzo[c][2,6]naphthyridine-8-carboxylic acid | IC50 | 7.0 [1], 17.0 [2] |
 | 5-(3-Ethynylanilino)benzo[c][2,6]naphthyridine-8-carboxylic acid | IC50 | 3.0 [1], 70.0 [2] |
 | N-(3-Chlorophenyl)-8-(2H-tetrazol-5-yl)benzo[c][2,6]naphthyridin-5-amine | IC50 | 45.0 [1], 1016.0 [2] |
 | 5-(3-Chloroanilino)-3-(cyclopropylamino)pyrimido[4,5-c]quinoline-8-carboxylic acid | IC50 | 10.0 [1], 13.0 [2] |
 | 5-(3,5-Difluoroanilino)pyrimido[4,5-c]quinoline-8-carboxylic acid | IC50 | 6.0 [1], 269.0 [2] |
 | 5-(3-Fluoroanilino)pyrimido[4,5-c]quinoline-8-carboxylic acid | IC50 | 6.0 [1], 26.0 [2] |
 | 5-(3-Chloro-4-fluoroanilino)pyrimido[4,5-c]quinoline-8-carboxylic acid | IC50 | 10.0 [1], 1056.0 [2] |
 | 5-(3-Chloroanilino)-3-(ethylamino)pyrimido[4,5-c]quinoline-8-carboxylic acid | IC50 | 10.0 [1], 30.0 [2] |
 | 5-[3-(Trifluoromethyl)anilino]pyrimido[4,5-c]quinoline-8-carboxylic acid | IC50 | 11.0 [1], 98.0 [2] |
 | 4-(4,5,6,7-Tetrabromobenzimidazol-1-yl)butyric acid | Ki | 368.0 [1], 472.0 [2] |
 | 4-[4,5,6,7-Tetrabromo-2-(dimethylamino)benzimidazol-1-yl]butanoic acid | Ki | 456.0 [1], 860.0 [2] |
 | 3-[(4,5,6,7-Tetrabromo-1H-benzimidazol-2-yl)sulfanyl]propanoic acid | Ki | 116.0 [1], 172.0 [2] |
 | 3-(4,5,6,7-Tetrabromo-1-methylbenzimidazol-2-yl)sulfanylpropanoic acid | Ki | 112.0 [1], 137.0 [2] |
 | 4-(4,5,6,7-Tetrabromo-1-methylbenzimidazol-2-yl)sulfanylbutanoic acid | Ki | 88.0 [1], 501.0 [2] |
 | 2-(4,5,6,7-Tetrabromo-1-methylbenzimidazol-2-yl)sulfanylacetic acid | Ki | 13.0 [1], 143.0 [2] |
 | N-[3-[3-Cyano-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-5-yl]-1-(3-hydroxypropyl)indol-5-yl]acetamide | IC50 | 210.0 [1], 3000.0 [2] |
 | N-[1-[3-Cyano-7-[(1-methylpyrazol-3-yl)amino]pyrazolo[1,5-a]pyrimidin-5-yl]indol-6-yl]acetamide | IC50 | 16.0 [1], 24.0 [2] |
 | 7-(Cyclopropylamino)-5-[6-(methylsulfonylmethyl)indol-1-yl]pyrazolo[1,5-a]pyrimidine-3-carbonitrile | IC50 | 7.0 [1], 83.0 [2] |
 | N-[1-[3-Cyano-7-(3-pyrrolidin-1-ylpropylamino)pyrazolo[1,5-a]pyrimidin-5-yl]indol-6-yl]acetamide | IC50 | 18.0 [1], 860.0 [2] |
 | N-[3-[3-Cyano-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-5-yl]-1-methylindol-5-yl]acetamide | IC50 | 27.0 [1], 6000.0 [2] |
 | N-[1-[3-Cyano-7-(oxetan-3-ylamino)pyrazolo[1,5-a]pyrimidin-5-yl]indol-6-yl]acetamide | IC50 | 4.0 [1], 57.0 [2] |
 | N-[3-[3-Cyano-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-5-yl]-1-(2-hydroxyethyl)indol-5-yl]acetamide | IC50 | 500.0 [1], 3000.0 [2] |
 | 7-(Cyclopropylamino)-5-[6-(hydroxymethyl)indol-1-yl]pyrazolo[1,5-a]pyrimidine-3-carbonitrile | IC50 | 120.0 [1], 830.0 [2] |
 | N-[1-[3-Cyano-7-(4-hydroxybutylamino)pyrazolo[1,5-a]pyrimidin-5-yl]indol-6-yl]acetamide | IC50 | 30.0 [1], 190.0 [2] |
 | N-[1-[3-Cyano-7-(2-morpholin-4-ylethylamino)pyrazolo[1,5-a]pyrimidin-5-yl]indol-6-yl]acetamide | IC50 | 30.0 [1], 460.0 [2] |
 | N-[1-[3-Cyano-7-(2-pyrrolidin-1-ylethylamino)pyrazolo[1,5-a]pyrimidin-5-yl]indol-6-yl]acetamide | IC50 | 40.0 [1], 780.0 [2] |
 | N-[1-[3-Cyano-7-[3-(dimethylamino)propylamino]pyrazolo[1,5-a]pyrimidin-5-yl]indol-6-yl]acetamide | IC50 | 30.0 [1], 1200.0 [2] |
 | 4-[2-(Dimethylamino)ethylamino]thieno[3,2-c]quinoline-7-carboxylic acid | IC50 | 277.0 [1], 50000.0 [2] |
 | 4-(Phenylamino)thieno[3,2-c]quinoline-7-carboxylic acid | IC50 | 310.0 [1], 15700.0 [2] |
 | 4-(3-Fluoroanilino)thieno[3,2-c]quinoline-7-carboxylic acid | IC50 | 68.0 [1], 3564.0 [2] |
 | 4-(3-Ethynylanilino)thieno[3,2-c]quinoline-7-carboxylic acid | IC50 | 28.0 [1], 8360.0 [2] |
 | N-(3-Chlorophenyl)-7-(2H-tetrazol-5-yl)thieno[3,2-c]quinolin-4-amine | IC50 | 181.0 [1], 9590.0 [2] |
 | N-(3-Fluorophenyl)-7-(2H-tetrazol-5-yl)thieno[3,2-c]quinolin-4-amine | IC50 | 96.0 [1], 4426.0 [2] |
 | 3-(Cyclopropylmethylamino)-5-(3-ethynylanilino)pyrimido[4,5-c]quinoline-8-carboxylic acid | IC50 | 27.0 [1], 50.0 [2] |
 | 4-(3,5-Dichloroanilino)thieno[3,2-c]quinoline-7-carboxylic acid | IC50 | 35.0 [1], 580.0 [2] |
 | 5-[2-(3-Fluorophenyl)ethylamino]benzo[c][2,6]naphthyridine-8-carboxylic acid | IC50 | 7.0 [1], 3600.0 [2] |
 | Methyl 5-anilinobenzo[c][2,6]naphthyridine-8-carboxylate | IC50 | 200.0 [1], 19870.0 [2] |
 | 4-(3-Fluoroanilino)-[1,3]thiazolo[4,5-c]quinoline-7-carboxylic acid | IC50 | 146.0 [1], 25800.0 [2] |
 | 5-(3-Chloro-4-fluoroanilino)-3-(2-methoxyethylamino)pyrimido[4,5-c]quinoline-8-carboxylic acid | IC50 | 47.0 [1], 52.0 [2] |
 | N-(4-Chloro-3-fluorophenyl)-8-(2H-tetrazol-5-yl)benzo[c][2,6]naphthyridin-5-amine | IC50 | 52.0 [1], 220.0 [2] |
 | Methyl 5-(3-methoxyanilino)benzo[c][2,6]naphthyridine-8-carboxylate | IC50 | 25000.0 [1], 50000.0 [2] |
 | 5-(3,5-Difluoroanilino)benzo[c][2,6]naphthyridine-8-carboxylic acid | IC50 | 5.0 [1], 1351.0 [2] |
 | 5-[2-(3-Chlorophenyl)ethylamino]benzo[c][2,6]naphthyridine-8-carboxylic acid | IC50 | 5.0 [1], 640.0 [2] |
 | 4-(3,5-Difluoroanilino)thieno[3,2-c]quinoline-7-carboxylic acid | IC50 | 70.0 [1], 4338.0 [2] |
 | 5-(3-Ethynylanilino)-3-(2-methoxyethylamino)pyrimido[4,5-c]quinoline-8-carboxylic acid | IC50 | 10.0 [1], 40.0 [2] |
 | N-(3-Fluorophenyl)-8-(2H-tetrazol-5-yl)benzo[c][2,6]naphthyridin-5-amine | IC50 | 47.0 [1], 630.0 [2] |
 | 3-(2-Ethoxyethylamino)-5-(3-ethynylanilino)pyrimido[4,5-c]quinoline-8-carboxylic acid | IC50 | 171.0 [1], 172.0 [2] |
 | 5-(3-Ethynylanilino)-3-(oxolan-2-ylmethylamino)pyrimido[4,5-c]quinoline-8-carboxylic acid | IC50 | 11.0 [1], 114.0 [2] |
 | 4-(3-Cyanoanilino)thieno[3,2-c]quinoline-7-carboxylic acid | IC50 | 81.0 [1], 10660.0 [2] |
 | N-Methyl-3-[[7-(2H-tetrazol-5-yl)thieno[3,2-c]quinolin-4-yl]amino]benzamide | IC50 | 283.0 [1], 37890.0 [2] |
 | 5-(3-Chloro-4-fluoroanilino)-3-(cyclopropylamino)pyrimido[4,5-c]quinoline-8-carboxylic acid | IC50 | 30.0 [1], 83.0 [2] |
 | 3-Amino-5-(3-chloro-4-fluoroanilino)pyrimido[4,5-c]quinoline-8-carboxylic acid | IC50 | 7.0 [1], 44.0 [2] |
 | Methyl 5-(3-chloro-4-fluoroanilino)benzo[c][2,6]naphthyridine-8-carboxylate | IC50 | 1661.0 [1], 7066.0 [2] |
Calculator
